Financhill
Back

Cassava Sciences Quote, Financials, Valuation and Earnings

Buy
76

SAVA
Cassava Sciences

Last Price:
46.18
Seasonality Move:
3.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Cassava Sciences Price Quote

$46.18

Cassava Sciences Key Stats

Buy
76
Cassava Sciences (SAVA) is a Buy

Day range:
$43.32 - $46.89
52-week range:
$13.84 - $100.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
44.90
P/B ratio:
8.48%

Volume:
3.5M
Avg. volume:
5.5M
1-year change:
-32.61%
Market cap:
$1.9B
Revenue:
$0
EPS:
$-1.51

How Much Does Cassava Sciences Make?

Data Unavailable

Is Cassava Sciences Growing As A Company?

Data Unavailable

Cassava Sciences Stock Price Performance

  • Did Cassava Sciences Stock Go Up Last Month?
    Cassava Sciences share price went up by 57.13% last month
  • Did SAVA's Share Price Rise Over The Last Year?
    SAVA share price fell by -32.61% over the past 1 year

What Is Cassava Sciences 52-Week High & Low?

Cassava Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cassava Sciences?

  • How Much Debt Does Cassava Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cassava Sciences Have?
    Cash and short term investments quarterly total is $197.2M
  • What Is Cassava Sciences’s Book Value Per Share?
    Book value per share is 5.45

Is Cassava Sciences Cash Flow Positive?

  • What Is SAVA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$57.4M
  • What Is Cassava Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $405K
  • What Is Cassava Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$24M

Cassava Sciences Return On Invested Capital

Data Unavailable

Cassava Sciences Earnings Date & Stock Price

Cassava Sciences Competitors

  • Who Are Cassava Sciences's Competitors?
    Below is a list of companies who compete with Cassava Sciences or are related in some way:
    • Artelo Biosciences Inc (ARTL)
    • Corcept Therapeutics Inc (CORT)
    • Heron Therapeutics Inc (HRTX)
    • Alaunos Therapeutics Inc (TCRT)
    • Tonix Pharmaceuticals Holding Corp (TNXP)

Cassava Sciences Dividend Yield

Data Unavailable

Cassava Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 3.03%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 1
Price Target: 58.67
Upside from Last Price: 27.04%

Major Shareholders

  • How many SAVA shares are owned by institutional investors?
    13.7M SAVA shares are owned by institutional investors
  • How many SAVA shares are owned by insiders?
    2.1M SAVA shares are owned by insiders